4//SEC Filing
Revance Therapeutics, Inc. 4
Accession 0001209191-15-008043
CIK 0001479290operating
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 7:07 PM ET
Size
7.3 KB
Accession
0001209191-15-008043
Insider Transaction Report
Form 4
Bertolino Arthur Peter
EVP and Chief Medical Officer
Transactions
- Award
Stock Option (Right to buy)
2015-01-28+34,445→ 34,445 totalExercise: $16.23Exp: 2025-01-27→ Common Stock (34,445 underlying) - Award
Common Stock
2015-01-28+6,078→ 45,453 total
Footnotes (2)
- [F1]The shares subject to the Restricted Stock Award shall vest in three (3) equal annual installments from January 28, 2015, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
- [F2]The shares subject to the Stock Option Grant shall vest in forty-eight (48) equal monthly installments from January 28, 2015, subject to Reporting Person's Continuous Service (as defined in the Plan) on each vesting date.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 7:07 PM ET
- Size
- 7.3 KB